Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.15)
# 2,169
Out of 4,479 analysts
144
Total ratings
43.48%
Success rate
-9.63%
Average return
Main Sectors:
Top Industries:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CARM Carisma Therapeutics | Reiterates: Buy | $8 | $1.44 | +455.56% | 10 | Jun 28, 2024 | |
| LYEL Lyell Immunopharma | Downgrades: Neutral | $6 → $1 | $1.51 | -33.77% | 7 | Jun 27, 2024 | |
| CTMX CytomX Therapeutics | Reiterates: Neutral | n/a | $1.32 | - | 3 | Jun 27, 2024 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $65 | $51.30 | +26.71% | 18 | Jun 26, 2024 | |
| RANI Rani Therapeutics Holdings | Reiterates: Buy | $13 | $3.87 | +235.92% | 11 | Jun 25, 2024 | |
| NGNE Neurogene | Reiterates: Buy | $51 | $38.46 | +32.61% | 9 | Jun 20, 2024 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $54 | $15.77 | +242.42% | 8 | Jun 17, 2024 | |
| LEGN Legend Biotech | Reiterates: Buy | $73 | $44.74 | +63.16% | 23 | Jun 6, 2024 | |
| LXEO Lexeo Therapeutics | Initiates: Buy | $22 | $14.02 | +56.92% | 1 | Jun 6, 2024 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $23 | $16.70 | +37.72% | 11 | Jun 5, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $11 | $2.21 | +397.74% | 12 | Jun 4, 2024 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $33.11 | +202.02% | 5 | May 21, 2024 | |
| MGX Metagenomi | Reiterates: Buy | $10 | $4.23 | +136.41% | 2 | May 15, 2024 | |
| RPHM Reneo Pharmaceuticals | Reiterates: Neutral | $1.5 | $1.51 | -0.66% | 4 | May 14, 2024 | |
| TIL Instil Bio | Reiterates: Buy | $18 | $10.04 | +79.28% | 6 | May 13, 2024 | |
| RLYB Rallybio | Reiterates: Buy | $9 | $1.20 | +650.00% | 9 | May 10, 2024 | |
| VERV Verve Therapeutics | Reiterates: Buy | $15 | $5.00 | +200.00% | 1 | May 9, 2024 | |
| ADTX Aditxt | Maintains: Buy | $4 → $61 | $1.47 | +4,063.82% | 2 | Sep 6, 2023 | |
| TCBP TC Biopharm (Holdings) | Maintains: Buy | $1,800 → $1,400 | $0.89 | +156,973.94% | 2 | Apr 27, 2023 |
Carisma Therapeutics
Jun 28, 2024
Reiterates: Buy
Price Target: $8
Current: $1.44
Upside: +455.56%
Lyell Immunopharma
Jun 27, 2024
Downgrades: Neutral
Price Target: $6 → $1
Current: $1.51
Upside: -33.77%
CytomX Therapeutics
Jun 27, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.32
Upside: -
Halozyme Therapeutics
Jun 26, 2024
Reiterates: Buy
Price Target: $65
Current: $51.30
Upside: +26.71%
Rani Therapeutics Holdings
Jun 25, 2024
Reiterates: Buy
Price Target: $13
Current: $3.87
Upside: +235.92%
Neurogene
Jun 20, 2024
Reiterates: Buy
Price Target: $51
Current: $38.46
Upside: +32.61%
Cartesian Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $54
Current: $15.77
Upside: +242.42%
Legend Biotech
Jun 6, 2024
Reiterates: Buy
Price Target: $73
Current: $44.74
Upside: +63.16%
Lexeo Therapeutics
Jun 6, 2024
Initiates: Buy
Price Target: $22
Current: $14.02
Upside: +56.92%
Tyra Biosciences
Jun 5, 2024
Reiterates: Buy
Price Target: $23
Current: $16.70
Upside: +37.72%
Century Therapeutics
Jun 4, 2024
Reiterates: Buy
Price Target: $11
Current: $2.21
Upside: +397.74%
Korro Bio
May 21, 2024
Reiterates: Buy
Price Target: $100
Current: $33.11
Upside: +202.02%
Metagenomi
May 15, 2024
Reiterates: Buy
Price Target: $10
Current: $4.23
Upside: +136.41%
Reneo Pharmaceuticals
May 14, 2024
Reiterates: Neutral
Price Target: $1.5
Current: $1.51
Upside: -0.66%
Instil Bio
May 13, 2024
Reiterates: Buy
Price Target: $18
Current: $10.04
Upside: +79.28%
Rallybio
May 10, 2024
Reiterates: Buy
Price Target: $9
Current: $1.20
Upside: +650.00%
Verve Therapeutics
May 9, 2024
Reiterates: Buy
Price Target: $15
Current: $5.00
Upside: +200.00%
Aditxt
Sep 6, 2023
Maintains: Buy
Price Target: $4 → $61
Current: $1.47
Upside: +4,063.82%
TC Biopharm (Holdings)
Apr 27, 2023
Maintains: Buy
Price Target: $1,800 → $1,400
Current: $0.89
Upside: +156,973.94%